NCT00999531View on ClinicalTrials.gov

A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial of GS-9411 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

March 31, 2010

Conditions

Cystic FibrosisMucociliary ClearanceAirway Hydration

Interventions

DRUG

GS-9411

Inhaled GS-9411 dissolved in sterile saline

DRUG

Placebo

Inhaled Placebo, sterile saline

Trial Locations (1)

Unknown

Nucleus Network, Ltd., Melbourne

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY